Source: Journal of Huntington's disease [J Huntingtons Dis] 2016 Dec 15; Vol. 5 (4), pp. 347-355.Publisher: IOS Press Country of Publication: Netherlands NLM ID: 101589965 Publication Model: Print Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Formation of AR-SMRT binding in prostate cancer cells treated with natural histone deacetylase inhibitor.

Authors : Trtková K; Laboratory of Molecular Pathology and Department of Pathology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, the Czech Republic. ; Pašková L

Subjects: Histone Deacetylase Inhibitors/Histone Deacetylase Inhibitors/Histone Deacetylase Inhibitors/*therapeutic use ; Nuclear Receptor Co-Repressor 2/Nuclear Receptor Co-Repressor 2/Nuclear Receptor Co-Repressor 2/*metabolism ; Prostatic Neoplasms/Prostatic Neoplasms/Prostatic Neoplasms/*drug therapy

Source: Cancer biomarkers : section A of Disease markers [Cancer Biomark] 2010; Vol. 7 (2), pp. 79-90.Publisher: IOS Press Country of Publication: Netherlands NLM ID: 101256509 Publication Model: Print Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Protocadherin 10 is frequently downregulated by promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer.

Authors : Tang X; Department of respiratory disease, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.; Yin X

Subjects: Genes, Tumor Suppressor* ; Promoter Regions, Genetic*; Cadherins/Cadherins/Cadherins/*genetics

Source: Cancer biomarkers : section A of Disease markers [Cancer Biomark] 2012-2013; Vol. 12 (1), pp. 11-9.Publisher: IOS Press Country of Publication: Netherlands NLM ID: 101256509 Publication Model: Print Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

The pan-deacetylase inhibitor panobinostat inhibits growth of hepatocellular carcinoma models by alternative pathways of apoptosis.

Authors : Di Fazio P; Department of Medicine 1, University Hospital Erlangen, Erlangen, Germany.; Schneider-Stock R

Subjects: Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*drug therapy ; Fibroblasts/Fibroblasts/Fibroblasts/*drug effects ; Histone Deacetylase Inhibitors/Histone Deacetylase Inhibitors/Histone Deacetylase Inhibitors/*pharmacology

Source: Cellular oncology : the official journal of the International Society for Cellular Oncology [Cell Oncol] 2010 Jan 01; Vol. 32 (4), pp. 285-300.Publisher: IOS Press Country of Publication: Netherlands NLM ID: 101219418 Publication Model: Print Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Chromatin-modifying agents increase transcription of CYP46A1, a key player in brain cholesterol elimination.

Authors : Milagre I; iMed.UL-Research Institute for Medicines and Pharmaceutical Sciences, Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal.; Nunes MJ

Subjects: Azacitidine/Azacitidine/Azacitidine/*analogs & derivatives ; Cholesterol/Cholesterol/Cholesterol/*metabolism ; DNA Modification Methylases/DNA Modification Methylases/DNA Modification Methylases/*antagonists & inhibitors

Source: Journal of Alzheimer's disease : JAD [J Alzheimers Dis] 2010; Vol. 22 (4), pp. 1209-21.Publisher: IOS Press Country of Publication: Netherlands NLM ID: 9814863 Publication Model: Print Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Identification of predictive biomarkers for the histone deacetylase inhibitor belinostat in a panel of human cancer cell lines.

Authors : Dejligbjerg M; Experimental Pathology Unit, National University Hospital, Copenhagen Biocenter, Ole Maaloes Vej 5, 2200 Copenhagen, Denmark. ; Grauslund M

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*pharmacology ; Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*genetics ; Drug Resistance, Neoplasm/Drug Resistance, Neoplasm/Drug Resistance, Neoplasm/*genetics

Source: Cancer biomarkers : section A of Disease markers [Cancer Biomark] 2008; Vol. 4 (2), pp. 101-9.Publisher: IOS Press Country of Publication: Netherlands NLM ID: 101256509 Publication Model: Print Cited Medium: Print

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Protocadherin 10 is frequently downregulated by promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer

Authors : Guosheng Ren; Li Chen; Xuedong Yin

Subjects: Cancer Research; Lung Neoplasms; Tumor suppressor gene

Source: Cancer Biomarkers. 12:11-19

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Identification of predictive biomarkers for the histone deacetylase inhibitor belinostat in a panel of human cancer cell lines

Authors : Morten Grauslund; Peter Buhl Jensen; Ib Jarle Christensen

Subjects: Cancer Research; medicine.drug_class; Blotting, Western

Source: Cancer Biomarkers. 4:101-109

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

LBH589, A Hydroxamic Acid-Derived HDAC Inhibitor, is Neuroprotective in Mouse Models of Huntington's Disease.

Formation of AR-SMRT binding in prostate cancer cells treated with natural histone deacetylase inhibitor.

Protocadherin 10 is frequently downregulated by promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer.

The pan-deacetylase inhibitor panobinostat inhibits growth of hepatocellular carcinoma models by alternative pathways of apoptosis.

Chromatin-modifying agents increase transcription of CYP46A1, a key player in brain cholesterol elimination.

Identification of predictive biomarkers for the histone deacetylase inhibitor belinostat in a panel of human cancer cell lines.

Protocadherin 10 is frequently downregulated by promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer

Identification of predictive biomarkers for the histone deacetylase inhibitor belinostat in a panel of human cancer cell lines

اتصل بنا

اتبع